4D Molecular Therapeutics’ 4D-110 receives FDA orphan drug designation for choroideremia

4D Molecular Therapeutics (4DMT), a prominent California-based gene therapy firm, has achieved a significant milestone with the US Food and Drug Administration (FDA) granting orphan ... Read More